ERS Genomics and Lepton Pharmaceuticals LTD Enter CRISPR/Cas9 License Agreement
/PRNewswire/ -- ERS Genomics Limited ('ERS') is pleased to announce a new license agreement with Lepton Pharmaceuticals LTD ('Lepton"). This is a non-exclusive...
Source: prnewswire.com